Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,382.00
Bid: 1,378.00
Ask: 1,386.00
Change: 10.00 (0.73%)
Spread: 8.00 (0.581%)
Open: 1,380.00
High: 1,386.00
Low: 1,380.00
Prev. Close: 1,372.00
AVON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 Dec 2014 09:52

RNS Number : 4475Y
Avon Rubber PLC
01 December 2014
 

1 December 2014

 

Avon Rubber p.l.c. ("the Company")

Directors' and PDMRs' Interest in Shares

On the 28 November 2014, pursuant to the Company's deferred bonus arrangement, a portion of the annual bonus payments due to the Executive Directors and certain PDMRs in respect of the 2013/14 financial year were deferred into Company shares. 25% of the annual bonus linked to financial targets, as distinct from personal performance targets, was subjected to tax and national insurance/social security and the net amount was used to purchase Company shares. The shares are to be held for two years and are not subject to the Company's shareholding guidelines. The table below sets out the number of deferred bonus shares for each Executive Director and PDMR. This is the first time this arrangement has been implemented under the Remuneration Policy approved by shareholders in February 2014.

Executive Directors

Deferred bonus shares

Peter Slabbert

7,477

Andrew Lewis

5,710

PDMRs

Miles Ingrey-Counter

1,824

Paul McDonald

1,809

John Kime

2,600

 

In addition, as disclosed in the 2014 annual report, awards representing 100% of the maximum possible award under the Avon Rubber p.l.c. Performance Share Plan 2010, were granted to Executive Directors, persons discharging managerial responsibilities ('PDMRs') and other employees (together 'Participants') on 1 December 2011 ('the 2011 Awards').

The Awards were made subject to performance conditions based on the Company's Total Shareholder Return ('TSR') and Earnings Per Share ('EPS'), to be measured over a 3 year performance period which commenced on 1 October 2011 and ended on 30 September 2014. The Company's TSR performance by reference to the comparator group was measured over the 5 days following the announcement of the Company's annual results for the year ended 30 September 2014. The Company's EPS performance was measured by reference to the EPS in the 2014 year end results.

The Remuneration Committee confirmed on 28 November 2014 that 96% of the Awards vested.

The Company received valid notices from the Participants in respect of the 2011 Awards. As a result, on 28 November 2014, the UK Participants, pursuant to the terms of the relevant joint ownership awards, sold their vested interests over all jointly owned shares in the market and exercised their nil cost options to acquire whole shares in the Company (all tax and National Insurance liabilities associated with the vesting of the 2011 Awards have been met out of the sale proceeds due to the UK Participants). US Participants have acquired whole shares pursuant to their 2011 Awards and sold a number of shares to meet tax and social security liabilities. A number of sales by Participants and their connected persons were also carried out for personal reasons.

Following these transactions, in accordance with the shareholding guidelines referred to in the annual report, both the Executive Directors have a retained shareholding equivalent to at least two times base salary.

The table below sets out the total number of shares over which the 2011 Awards were made to the Executive Directors and PDMRs, total disposals, the net increase or decrease in the shares owned by the relevant individuals and their total shareholdings following these transactions (details in respect of connected persons are set out in the notes):

Total Vested Award*

Whole shares acquired under nil cost option or conditional award

Whole shares disposed**

Net increase/(decrease) in shareholding

Total shareholding***

Executive Directors

Peter Slabbert

84,000

39,548

104,548

(65,000)

137,690

Andrew Lewis

48,000

22,599

62,599

(40,000)

81,155

PDMRs

Miles Ingrey-Counter

20,701

9,746

9,746

nil

40,303

Paul McDonald

21,600

10,170

nil

10,170

49,044

John Kime (US)

27,020

27,020

9,282

17,738

33,257

*96% of the total number of the 2011 Awards. Each executive held an interest in the number of shares shown in the above table which was sold, on 28 November, following the vesting of the 2011 Awards. The proceeds due to the executives on sale of the jointly owned shares were determined by the 2011 Joint Ownership Agreements as £3.72 per share.

** Some of the whole shares disposed were sold from pre-existing holdings by spouses and, in the case of Peter Slabbert, his son. Specifically, Desiree Slabbert sold 53,000 shares, Simon Slabbert sold 12,000 shares, Karen Lewis sold 40,000 shares and Emma Ingrey-Counter sold 3,000 shares.

**\* This excludes interests held under unvested joint ownership awards. The total shareholding number includes shares held by connected persons. In respect of Peter Slabbert, the total share number is constituted by 27,069 shares held by Peter Slabbert, 102,621 shares held by Desiree Slabbert and 8,000 shares held by Simon Slabbert. In the case of Andrew Lewis, the total share number is constituted by 804 shares held by Andrew Lewis and 80,351 shares held by Karen Lewis. In the case of Miles Ingrey-Counter, the total share number is constituted by 3,804 shares held by Miles Ingrey-Counter and 36,499 shares held by Emma Ingrey-Counter. In the case of Paul McDonald, the total share number is constituted by 28,607 shares held by Paul McDonald and 20,437 shares held by Deborah McDonald. John Kime's shareholding is in his own name.

Other employees accounted for total vested awards of 125,809 shares. Other UK participants sold their jointly owned interests in 50,477 shares and acquired nil cost options over 23,765 whole shares, of which 8,529 were sold for personal reasons. Other US participants acquired 75,332 whole shares of which 48,441 were sold to pay tax and for personal reasons.

Contact Information:

Peter Slabbert, Chief Executive

01225 896870

Andrew Lewis, Group Finance Director

Miles Ingrey-Counter, Company Secretary

01225 896830

01225 896850

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUAVKRSRAURRA
Date   Source Headline
21st May 20247:04 amRNSInterim Results
9th May 20247:00 amRNSUK MoD General Service Respirator order
8th May 202410:00 amRNSDirectors'/PDMR Shareholdings
3rd May 20248:34 amRNSHolding(s) in Company
18th Apr 20241:00 pmRNSHolding(s) in Company
8th Apr 202411:00 amRNSDirectors'/PDMR Shareholdings
5th Apr 20247:00 amRNSHolding(s) in Company
25th Mar 20244:30 pmRNSDirector/PDMR Shareholding
14th Mar 20249:17 amRNSAppointment of Non-Executive Director
6th Mar 20244:17 pmRNSDirectors'/PDMR Shareholdings
20th Feb 20245:00 pmRNSFinal Dividend Currency Exchange Rate
13th Feb 20247:00 amRNSHolding(s) in Company
8th Feb 20247:00 amRNSCapital Markets Event
6th Feb 202410:00 amRNSDirectors'/PDMR Shareholdings
5th Feb 20247:00 amRNSNext Generation IHPS Delivery Order
30th Jan 20241:00 pmRNSDirector/PDMR Shareholding
26th Jan 20242:00 pmRNSResult of AGM
26th Jan 20247:00 amRNSAGM Trading Update
25th Jan 20243:00 pmRNSPDMR Shareholdings
24th Jan 20247:00 amRNSU.S. Defense Logistics Agency helmet order
15th Jan 20247:00 amRNSGerman Navy underwater rebreather contract
11th Jan 20244:00 pmRNSDirectors'/PDMR Shareholdings
4th Jan 20247:00 amRNSNotice of Capital Markets Event
21st Dec 20233:00 pmRNSHolding(s) in Company
14th Dec 202310:00 amRNSPDMRs’ Interest in Shares
12th Dec 20233:00 pmRNSNotice of Annual Report, Accounts and 2024 AGM
7th Dec 20239:28 amRNSDirector/PDMR Shareholding
27th Nov 20239:00 amRNSHolding(s) in Company
23rd Nov 20236:00 pmRNSDirector/PDMR Shareholding
23rd Nov 202312:00 pmRNSDirector/PDMR Shareholding
23rd Nov 202312:00 pmRNSDirector/PDMR Shareholding
21st Nov 20232:00 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSPreliminary Results
7th Nov 20234:00 pmRNSDirector/PDMR Shareholding
20th Oct 20233:00 pmRNSNotification of PDMR Dealing
20th Oct 20231:00 pmRNSDirector/PDMR Shareholding
18th Oct 20236:00 pmRNSDirector/PDMR Shareholding
17th Oct 20233:00 pmRNSDirector/PDMR Shareholding
17th Oct 20233:00 pmRNSDirector/PDMR Shareholding
13th Oct 20237:00 amRNSTrading Update & Restatement of FY22 Results
6th Oct 20231:00 pmRNSDirectors'/PDMR Shareholdings
21st Aug 20233:00 pmRNSInterim Dividend Currency Exchange Rate
8th Aug 20231:00 pmRNSDirector/PDMR Shareholding
25th Jul 20232:00 pmRNSHolding(s) in Company
19th Jul 20234:00 pmRNSHolding(s) in Company
14th Jul 202312:00 pmRNSDirector/PDMR Shareholding
10th Jul 202312:00 pmRNSDirector/PDMR Shareholding
10th Jul 20238:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSU.S. Army Next-Generation Ballistic Helmet Order
27th Jun 20235:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.